Kineret 100 mg/0
As listed in the register: Kineret 100 mg/0,67 ml/ (150 mg/ml), oplossing voor injectie
100 mg/0,67 ml + 150 mg/ml · oplossing voor injectie
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Anakinra
- Made by
- Amgen Europe B.V.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Kineret). It describes the substance, not this exact product.
KINERET blocks the biologic activity of IL-1 alpha and beta by competitively inhibiting IL-1 binding to the interleukin-1 type I receptor (IL-1RI), which is expressed in a wide variety of tissues and organs.
IL-1 production is induced in response to inflammatory stimuli and mediates various physiologic responses including inflammatory and immunological responses.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-04-03
Safety of the active substance
From the US prescribing label for the same active substance (Kineret). It describes the substance, not this exact product.
- KINERET is contraindicated in patients with known hypersensitivity to E coli -derived proteins, KINERET, or any components of the product [see Hypersensitivity Reactions ( 5.3 )].
- Known hypersensitivity to E coli -derived proteins, Kineret, or to any component of the product.
The most common reason for withdrawing from studies.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
European UnionNo exact match for this strength and form
SpainNo exact match for this strength and form
FranceNo exact match for this strength and form
CanadaNo exact match for this strength and form
Details
| Made by | Amgen Europe B.V. |
|---|---|
| Active substance | Anakinra |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 100 mg/0,67 ml + 150 mg/ml |
| Form | oplossing voor injectie |
| Classification | L04AC03 · Cancer treatments and immune-system medicines |
| Route | subcutaan gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Kineret 100 mg/0,67 ml/ (150 mg/ml), oplossing voor injectie |
| RVG | EU/1/02/203 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).